Pfizer Recalls All of Its Sickle Cell Disease Treatment Over Safety Concerns
Pfizer is withdrawing all of its sickle cell disease drug, Oxbryta, worldwide because of safety concerns. Pfizer ( PFE) shares declined Thursday after the drug maker recalled all lots of its sickle cell disease medicine worldwide because of concerns it could lead to severe pain and possibly death in patients.
Eric Boodman, a STAT general assignment reporter, is the author of a series about sickle cell disease and forced sterilizations. She knew what it was to have pain she couldn’t put into words ...
Meanwhile, in Lawton, about a dozen people showed up at the Abundant Life Christian Church to donate blood for the Sickle ...
Officials hosted a tour Friday and launched a groundbreaking pediatric treatment for sickle cell disease. Yunigen officials, including Chief Executive Officer and Vice President Charles Otieno and ...
Gene therapy for sickle cell disease remains a tough business model — and may never work, @adamfeuerstein writes.
Sickle cell patients say they struggle to receive appropriate care, especially in emergency room settings. Overcoming some of ...
Rochester, N.Y. The classmates of a young woman who passed away from sickle cell disease are giving back in her memory.
Groundbreaking pharmaceutical firm Yunigen welcomed a high-ranking Kenyan official to its R&D and manufacturing facility ...
September is National Sickle Cell Awareness Month and Carillion Clinic Sickle Cell Collaborative is holding an awareness walk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback